VERACYTE, INC. 8-K

What Happened

• Veracyte, Inc. announced in an 8-K filed June 11, 2026 that its stockholders approved an amendment to the company’s 2023 Equity Incentive Plan at the June 10, 2026 Annual Meeting. The amendment increases the number of shares reserved for issuance under the 2023 Plan by 3,500,000 shares. The Board had previously approved the amendment on April 8, 2026, subject to stockholder approval.

Key Details

• Vote date: June 10, 2026 (Annual Meeting).
• Share increase: 3,500,000 shares of common stock added to the 2023 Equity Incentive Plan.
• Prior disclosure: The amendment was described in the company’s proxy statement filed April 22, 2026.
• Filing: The amended 2023 Equity Incentive Plan is filed as Exhibit 10.1 to the Form 8‑K.

Why It Matters

• The approved increase gives Veracyte additional shares to grant as equity compensation to employees, directors and consultants, supporting hiring, retention and incentive programs.
• For investors, the change can lead to future dilution if new awards are issued and fully vest/exercised; the filing documents the exact increase and provides the amended plan for review.